Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|July 1, 2009
Ciprofloxacin dosage and emergence of resistance in human commensal bacteriaBruno Fantin, Xavier Duval, Laurent Massias, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditisJuliette Pavie, Agnès Lefort, Marie-Cécile Ploy, et al.
Emerging Infectious Diseases|February 9, 2008
Plasmodium falciparum malaria and atovaquone-proguanil treatment failureRémy Durand, Virginie Prendki, Johann Cailhol, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2020
Analysis of Paradoxical Efficacy of Carbapenems against Carbapenemase-Producing Escherichia coli in a Murine Model of Lethal PeritonitisAriane Roujansky, Victoire de Lastours, François Guérin, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 3, 2010
Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipientsChristophe Bazin, Amélie Guinedor, Caroline Barau, et al.
International Journal of Antimicrobial Agents|December 8, 2022
Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniaeBenjamin Davido, Anne-Claude Crémieux, Isabelle Vaugier, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2018
In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditisSophie Reissier, Azzam Saleh-Mghir, François Guerin, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Activity and diffusion of tigecycline (GAR-936) in experimental enterococcal endocarditisAgnès Lefort, Matthieu Lafaurie, Laurent Massias, et al.
Pageof 4